MFDS approves ‘Invossa K Inj,’ Korea’s first gene therapy

Published: 2017-07-14 16:28:00
Updated: 2017-07-14 10:01:36

The Ministry of Food and Drug Safety(MFDS) announced approval of ‘Invossa K Inj,’ a gene therapy for the treatment of osteoarthritis in the knee, on the 12th of July.

Gene therapy is a pharmaceutical product is that is a dielectric substance or has cells whose dielectric substance is transformed...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.